Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Lancet Haematol. 2018 Nov;5(11):e532–e542. doi: 10.1016/S2352-3026(18)30156-X

Table 3.

Grade 3 to 5 Adverse Events

Adverse Event Arm 1
AUC = 16K
No. (%)
Arm 2
AUC = 20K
No. (%)
P value
No of patients 49 48
Primary graft failure (Grade 4) 1 (2) 0 1.00
HEMATOLOGIC 3 (6) 2 (4) 1.00
 Grade 3 Red cell aplasia # 2 (4) 2 (4)
 Grade 3 Autoimmune hemolytic anemia 1 (2) 0
CARDIAC 1 (2) 0 1.00
 Grade 3 Congestive heart failure 1 (2) 0
HEPATIC 5 (10) 6 (13) 0.76
 Grade 3 Hyperbilirubinemia* 3 (6) 3 (6)
 Grade 4 Hyperbilirubinemia* 0 2 (4)
 Grade 3 Elevation of alkaline phosphatase 2 (4) 0
 Grade 3 Transaminitis 0 1 (2)
INFECTIONS** 24 (49) 25 (52) 0.84
 Grade 3 Viral infection 5 (10) 5 (10)
 Grade 3 Fungal infection 1 (2) 1 (2)
 Grade 3 Bacterial infection 12 (24) 14 (29)
 Grade 4 Bacterial infection 2 (4) 2 (4)
 Grade 5 Bacterial infection 4 (8) 3 (6)
Grade 3 Presumed viral encephalopathy 2 (4) 0 0.49
Grade 3 Neutropenic fever*** 8 (16) 16 (33) 0.06
Grade 3 Cellulitis 1 (2) 0 1.00
PULMONARY 3 (6) 11 (23) 0.02
 Grade 3 Engraftment syndrome 0 2 (4)
 Grade 3 IPS 2 (4) 8 (17)
 Grade 4 IPS 0 1 (2)
 Grade 5 Pneumonia 1 (2) 0
GASTROINTESTINAL 3 (6) 10 (21) 0.04
 Grade 3 Mucositis 3 (6) 9 (19)
 Grade 3 Neutropenic colitis 0 1 (2)
RENAL 1 (2) 1 (2) 1.00
 Grade 3 Renal insufficiency 1 (2) 1 (2)
#

due to major ABO incompatibility

*

Asymptomatic hyperbilirubinemia; resolved spontaneously. No cases of venoocclusive disease.

**

Organism documented.

***

Cultures negative; no obvious focus of infection.

Abbreviations: AUC, area under the curve; IPS, idiopathic pneumonia syndrome